Article info
PDFValvular heart disease
Original research
Anticoagulant prescribing for atrial fibrillation and risk of incident dementia
- Correspondence to Dr Charlotte Warren-Gash, Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; charlotte.warren-gash1{at}lshtm.ac.uk
Citation
Anticoagulant prescribing for atrial fibrillation and risk of incident dementia
Publication history
- Received May 14, 2021
- Accepted September 23, 2021
- First published October 13, 2021.
Online issue publication
January 08, 2022
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.